530 related articles for article (PubMed ID: 15727649)
21. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.
Schnider P; Binder M; Auff E; Kittler H; Berger T; Wolff K
Br J Dermatol; 1997 Apr; 136(4):548-52. PubMed ID: 9155956
[TBL] [Abstract][Full Text] [Related]
22. Palmar hyperhidrosis: long-term follow-up of nine children and adolescents treated with botulinum toxin type A.
Coutinho dos Santos LH; Gomes AM; Giraldi S; Abagge KT; Marinoni LP
Pediatr Dermatol; 2009; 26(4):439-44. PubMed ID: 19689521
[TBL] [Abstract][Full Text] [Related]
23. Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.
Bechara FG; Sand M; Achenbach RK; Sand D; Altmeyer P; Hoffmann K
Dermatol Surg; 2007 Aug; 33(8):924-7. PubMed ID: 17661934
[TBL] [Abstract][Full Text] [Related]
24. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.
Bechara FG; Gambichler T; Bader A; Sand M; Altmeyer P; Hoffmann K
J Am Acad Dermatol; 2007 Aug; 57(2):207-12. PubMed ID: 17368632
[TBL] [Abstract][Full Text] [Related]
25. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
Sahai A; Khan MS; Dasgupta P
J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
[TBL] [Abstract][Full Text] [Related]
27. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
Heckmann M; Plewig G;
Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin: a treatment for compensatory hyperhidrosis in the trunk.
Kim WO; Kil HK; Yoon KB; Noh KU
Dermatol Surg; 2009 May; 35(5):833-8; discussion 838. PubMed ID: 19389096
[TBL] [Abstract][Full Text] [Related]
29. Durability of botulinum toxin treatment for axillary hyperhidrosis.
Moffat CE; Hayes WG; Nyamekye IK
Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):188-91. PubMed ID: 19395290
[TBL] [Abstract][Full Text] [Related]
30. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents.
Kaymak Y; Taner E; Taner Y
Int J Dermatol; 2009 Jan; 48(1):41-6. PubMed ID: 19126049
[TBL] [Abstract][Full Text] [Related]
31. [Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A].
Kreyden OP; Burg G
Schweiz Med Wochenschr; 2000 Jul; 130(29-30):1084-90. PubMed ID: 10971942
[TBL] [Abstract][Full Text] [Related]
32. Effects of botulinum toxin-a therapy for palmar hyperhidrosis in plantar sweat production.
Gregoriou S; Rigopoulos D; Makris M; Liakou A; Agiosofitou E; Stefanaki C; Kontochristopoulos G
Dermatol Surg; 2010 Apr; 36(4):496-8. PubMed ID: 20180837
[TBL] [Abstract][Full Text] [Related]
33. Impact on quality of life of botulinum toxin treatments for essential blepharospasm.
MacAndie K; Kemp E
Orbit; 2004 Dec; 23(4):207-10. PubMed ID: 15590520
[TBL] [Abstract][Full Text] [Related]
34. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
[TBL] [Abstract][Full Text] [Related]
35. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K
Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136
[TBL] [Abstract][Full Text] [Related]
36. An assessment of anxiety in patients with primary hyperhidrosis before and after endoscopic thoracic sympathicolysis.
Ramos R; Moya J; Morera R; Masuet C; Perna V; Macia I; Escobar I; Villalonga R
Eur J Cardiothorac Surg; 2006 Aug; 30(2):228-31. PubMed ID: 16829107
[TBL] [Abstract][Full Text] [Related]
37. [Follow-up study of quality of life and treatment of eating disorder: dynamics of the depressive and anxiety symptoms].
Banaś A; Januszkiewicz-Grabias A; Radziwiłłowicz P; Smoczyński S
Psychiatr Pol; 2002; 36(6 Suppl):323-9. PubMed ID: 12647456
[TBL] [Abstract][Full Text] [Related]
38. The effect of cardiac rehabilitation on quality of life, anxiety and depression in patients with congestive heart failure. A randomized controlled trial, short-term results.
Kulcu DG; Kurtais Y; Tur BS; Gülec S; Seckin B
Eura Medicophys; 2007 Dec; 43(4):489-97. PubMed ID: 18084172
[TBL] [Abstract][Full Text] [Related]
39. Primary hyperhidrosis: Implications on symptoms, daily life, health and alcohol consumption when treated with botulinum toxin.
Shayesteh A; Boman J; Janlert U; Brulin C; Nylander E
J Dermatol; 2016 Aug; 43(8):928-33. PubMed ID: 26875781
[TBL] [Abstract][Full Text] [Related]
40. Compensatory hyperhidrosis: a consequence of truncal sympathectomy treated by video assisted application of botulinum toxin and reoperation.
Efthymiou CA; Thorpe JA
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1157-8. PubMed ID: 18450468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
